Canid Revenue and Competitors
Estimated Revenue & Valuation
- Canid's total funding is $2M.
Employee Data
- Canid has 39 Employees.
- Canid grew their employee count by 105% last year.
Canid's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Head Product and Operations | Reveal Email/Phone |
3 | Founding Account Executive | Reveal Email/Phone |
4 | Full-stack Developer | Reveal Email/Phone |
5 | Full-stack Developer | Reveal Email/Phone |
6 | Software Engineer | Reveal Email/Phone |
7 | Desarrollador de back-end | Reveal Email/Phone |
Canid Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 63 | 26% | N/A | N/A |
#2 | $1.7M | 40 | 21% | N/A | N/A |
#3 | N/A | 44 | 52% | N/A | N/A |
#4 | N/A | 21 | 24% | N/A | N/A |
#5 | N/A | 47 | 0% | N/A | N/A |
#6 | N/A | 59 | 44% | N/A | N/A |
#7 | N/A | 151 | 68% | N/A | N/A |
#8 | N/A | 82 | 37% | N/A | N/A |
#9 | N/A | 56 | 60% | N/A | N/A |
#10 | N/A | 50 | -2% | N/A | N/A |
What Is Canid?
Every kid should be vaccinated. Today, we're making it harder and harder for people to fulfill that mission. From the pediatrician, to the parent, to the payer, the layers of confusing, expensive and tedious work involved in vaccinating children is hindering our ability to succeed in one of the most important public health initiatives of the century.\n\nWith the COVID vaccine for children rolling out, we're about to throw an additional wrench at everyone involved.\n\nThat's why we created Canid, where we worry about all of the nitty gritty details of executing a vaccine program from financing, to technology, to inventory, etc. so pediatricians can instead focus on the children.
keywords:N/A$2M
Total Funding
39
Number of Employees
N/A
Revenue (est)
105%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $104.6M | 39 | -22% | $2B |
#2 | $7.8M | 39 | -7% | N/A |
#3 | $6.4M | 39 | -15% | N/A |
#4 | $3M | 39 | 8% | $16.5M |
#5 | $7.8M | 39 | -26% | N/A |